Analyst Expectations For BioLife Solns's Future
Analyst Expectations For BioLife Solns's Future
分析师对BioLife Solns未来的预期
The...BioLife Solns (NASDAQ:BLFS) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
BioLife Solns (纳斯达克股票代码:BLFS)在过去三个月内得到4位分析师的分析评级，展示了从看好到看淡各种不同的观点。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天内情绪的变化，并将它们与前几个月进行比较。
Analysts have recently evaluated BioLife Solns and provided 12-month price targets. The average target is $29.75, accompanied by a high estimate of $32.00 and a low estimate of $27.00. Marking an increase of 2.59%, the current average surpasses the previous average price target of $29.00.
分析师最近对 BioLife Solns 进行了评估，并给出了 12 个月的目标价。平均目标价为 $29.75，高估为 $32.00，低估为 $27.00。当前平均目标较之前的 $29.00 目标价提高了 2.59%。
Deciphering Analyst Ratings: An In-Depth Analysis
分析师评级解读：深入分析
The...
通...
登录免费看全文
登录/注册
热门讨论
FOMC维持利率但不确定性高企：美股后市走向如何？
🎙️讨论 1. 美联储强调政策路径存在“高度不确定性”，你更关注利率预期变化还是经济数据对市场的短期影响？ 2. 若核心通胀维持高位，哪类板块更具交易机会——防御型股票还是科技成长股？
Moo Live
03/20 02:25
联邦公开市场委员会新闻发布会，2025年3月19日